Survival analysis indicated that glioma patients exhibiting high BCAT1 expression and low CHIP expression had shorter overall survival compared to those with low BCAT1 expression and high CHIP expression (Fig. 8G, H). The gene discussed is BCAT1; the disease is central nervous system cancer.